Paramount's board has approved a plan to move the studio out of California if Attorney General Rob Bonta does not agree to settlement talks by October 1 amid an antitrust lawsuit over its $110 billion Warner Bros. acquisition. CEO David Ellison warned that the company could relocate to states like Tennessee or Texas to avoid mounting legal costs and a $7 million daily fee tied to the deal. The move aims to save $500 million annually in taxes and could involve selling studio lots in California, though Paramount intends to keep a creative presence in Hollywood. The dispute escalates as Bonta leads a multi-state lawsuit seeking to block the merger, with no settlement yet in sight.
Industrial Alliance Securities lowered Abeona Therapeutics' price target from $20 to $15 following a 14% stock drop after the company reported Q2 revenues of $11.4 million, missing analyst expectations. The company faces operational challenges with i...
Inovio Pharmaceuticals is progressing its DNA medicine pipeline with its lead candidate INO-3107 for Recurrent Respiratory Papillomatosis under FDA accelerated review, targeting a decision by October 30, 2026. The company raised $18.3 million in fund...
Morin Brit, a director at Life360, sold 15,582 shares of the company, generating $1 million from the transaction. This sale may indicate a personal financial decision or portfolio adjustment by the director. Investors might watch for any further insi...
AbCellera Biologics announced positive Phase 2 trial results for its experimental menopause drug ABCL635, which significantly reduced hot flash frequency by 83%. The stock surged 33.19% to a 52-week high of $11.32, boosting the company's market cap t...
TOMI Environmental Solutions reported a 118% year-over-year revenue increase to $2.25 million, surpassing analyst estimates of $1.84 million. The company also beat EPS expectations with a loss of $0.05 per share, better than the anticipated loss of $...
